0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Nicotinamide Mononucleotide Supplement Market Research Report 2024
Published Date: May 2024
|
Report Code: QYRE-Auto-37J14678
Home | Market Reports | Health| Nutrition| Vitamins & Supplements
Global Nicotinamide Mononucleotide Supplement Market Insights Forecast to 2029
BUY CHAPTERS

Global Nicotinamide Mononucleotide Supplement Market Research Report 2024

Code: QYRE-Auto-37J14678
Report
May 2024
Pages:110
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Nicotinamide Mononucleotide Supplement Market Size

The global Nicotinamide Mononucleotide Supplement market was valued at US$ 255 million in 2023 and is anticipated to reach US$ 357.8 million by 2030, witnessing a CAGR of 5.0% during the forecast period 2024-2030.

Nicotinamide Mononucleotide Supplement Market

Nicotinamide Mononucleotide Supplement Market

NMN supplements may help improve insulin sensitivity and heart function and reduce tiredness with few side effects.
A dietary supplement is a manufactured product intended to supplement one's diet by taking a pill, capsule, tablet, powder, or liquid. A supplement can provide nutrients either extracted from food sources or that are synthetic in order to increase the quantity of their consumption. The class of nutrient compounds includes vitamins, minerals, fiber, fatty acids, and amino acids. Dietary supplements can also contain substances that have not been confirmed as being essential to life, but are marketed as having a beneficial biological effect, such as plant pigments or polyphenols. Animals can also be a source of supplement ingredients, such as collagen from chickens or fish for example. These are also sold individually and in combination, and may be combined with nutrient ingredients. The European Commission has also established harmonized rules to help insure that food supplements are safe and appropriately labeled.
This report aims to provide a comprehensive presentation of the global market for Nicotinamide Mononucleotide Supplement, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nicotinamide Mononucleotide Supplement.

Report Scope

The Nicotinamide Mononucleotide Supplement market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nicotinamide Mononucleotide Supplement market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nicotinamide Mononucleotide Supplement manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Nicotinamide Mononucleotide Supplement Market Report

Report Metric Details
Report Name Nicotinamide Mononucleotide Supplement Market
Accounted market size in 2023 US$ 255 million
Forecasted market size in 2030 US$ 357.8 million
CAGR 5.0%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Powder
  • Tablets
  • Solution
  • Capsules
Segment by Application
  • Online Sales
  • Pharmacy Sales
  • Supermarket Sales
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Double Wood Supplements, Quicksilver Scientific, California Gold Nutrition, ProHealth Longevity, Renue by Science, Do Not Age, Nutriop, AFEGA Anti-Aging-Shop, Borealis, MAAC10 Formulas, Xi'an Angel Biotechnology Co., Ltd., Longevity Box, Age Science, Nutravita, Hebei Paihang Import And Export Co., Ltd., Aeternum, Toniiq, ProNutrition, Genex Formulas, Physicians Longevity, AlphaFit, Mega NMN, Lovita Foods, Jarrow Formulas, Body Union, Peak Performance
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Nicotinamide Mononucleotide Supplement manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Nicotinamide Mononucleotide Supplement in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Nicotinamide Mononucleotide Supplement Market growing?

Ans: The Nicotinamide Mononucleotide Supplement Market witnessing a CAGR of 5.0% during the forecast period 2024-2030.

What is the Nicotinamide Mononucleotide Supplement Market size in 2030?

Ans: The Nicotinamide Mononucleotide Supplement Market size in 2030 will be US$ 357.8 million.

Who are the main players in the Nicotinamide Mononucleotide Supplement Market report?

Ans: The main players in the Nicotinamide Mononucleotide Supplement Market are Double Wood Supplements, Quicksilver Scientific, California Gold Nutrition, ProHealth Longevity, Renue by Science, Do Not Age, Nutriop, AFEGA Anti-Aging-Shop, Borealis, MAAC10 Formulas, Xi'an Angel Biotechnology Co., Ltd., Longevity Box, Age Science, Nutravita, Hebei Paihang Import And Export Co., Ltd., Aeternum, Toniiq, ProNutrition, Genex Formulas, Physicians Longevity, AlphaFit, Mega NMN, Lovita Foods, Jarrow Formulas, Body Union, Peak Performance

What are the Application segmentation covered in the Nicotinamide Mononucleotide Supplement Market report?

Ans: The Applications covered in the Nicotinamide Mononucleotide Supplement Market report are Online Sales, Pharmacy Sales, Supermarket Sales

What are the Type segmentation covered in the Nicotinamide Mononucleotide Supplement Market report?

Ans: The Types covered in the Nicotinamide Mononucleotide Supplement Market report are Powder, Tablets, Solution, Capsules

1 Nicotinamide Mononucleotide Supplement Market Overview
1.1 Product Overview and Scope of Nicotinamide Mononucleotide Supplement
1.2 Nicotinamide Mononucleotide Supplement Segment by Type
1.2.1 Global Nicotinamide Mononucleotide Supplement Market Value Comparison by Type (2024-2030)
1.2.2 Powder
1.2.3 Tablets
1.2.4 Solution
1.2.5 Capsules
1.3 Nicotinamide Mononucleotide Supplement Segment by Application
1.3.1 Global Nicotinamide Mononucleotide Supplement Market Value by Application: (2024-2030)
1.3.2 Online Sales
1.3.3 Pharmacy Sales
1.3.4 Supermarket Sales
1.4 Global Nicotinamide Mononucleotide Supplement Market Size Estimates and Forecasts
1.4.1 Global Nicotinamide Mononucleotide Supplement Revenue 2019-2030
1.4.2 Global Nicotinamide Mononucleotide Supplement Sales 2019-2030
1.4.3 Global Nicotinamide Mononucleotide Supplement Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Nicotinamide Mononucleotide Supplement Market Competition by Manufacturers
2.1 Global Nicotinamide Mononucleotide Supplement Sales Market Share by Manufacturers (2019-2024)
2.2 Global Nicotinamide Mononucleotide Supplement Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Nicotinamide Mononucleotide Supplement Average Price by Manufacturers (2019-2024)
2.4 Global Nicotinamide Mononucleotide Supplement Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Nicotinamide Mononucleotide Supplement, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nicotinamide Mononucleotide Supplement, Product Type & Application
2.7 Nicotinamide Mononucleotide Supplement Market Competitive Situation and Trends
2.7.1 Nicotinamide Mononucleotide Supplement Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Nicotinamide Mononucleotide Supplement Players Market Share by Revenue
2.7.3 Global Nicotinamide Mononucleotide Supplement Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Nicotinamide Mononucleotide Supplement Retrospective Market Scenario by Region
3.1 Global Nicotinamide Mononucleotide Supplement Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Nicotinamide Mononucleotide Supplement Global Nicotinamide Mononucleotide Supplement Sales by Region: 2019-2030
3.2.1 Global Nicotinamide Mononucleotide Supplement Sales by Region: 2019-2024
3.2.2 Global Nicotinamide Mononucleotide Supplement Sales by Region: 2025-2030
3.3 Global Nicotinamide Mononucleotide Supplement Global Nicotinamide Mononucleotide Supplement Revenue by Region: 2019-2030
3.3.1 Global Nicotinamide Mononucleotide Supplement Revenue by Region: 2019-2024
3.3.2 Global Nicotinamide Mononucleotide Supplement Revenue by Region: 2025-2030
3.4 North America Nicotinamide Mononucleotide Supplement Market Facts & Figures by Country
3.4.1 North America Nicotinamide Mononucleotide Supplement Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Nicotinamide Mononucleotide Supplement Sales by Country (2019-2030)
3.4.3 North America Nicotinamide Mononucleotide Supplement Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Nicotinamide Mononucleotide Supplement Market Facts & Figures by Country
3.5.1 Europe Nicotinamide Mononucleotide Supplement Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Nicotinamide Mononucleotide Supplement Sales by Country (2019-2030)
3.5.3 Europe Nicotinamide Mononucleotide Supplement Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nicotinamide Mononucleotide Supplement Market Facts & Figures by Country
3.6.1 Asia Pacific Nicotinamide Mononucleotide Supplement Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Nicotinamide Mononucleotide Supplement Sales by Country (2019-2030)
3.6.3 Asia Pacific Nicotinamide Mononucleotide Supplement Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Nicotinamide Mononucleotide Supplement Market Facts & Figures by Country
3.7.1 Latin America Nicotinamide Mononucleotide Supplement Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Nicotinamide Mononucleotide Supplement Sales by Country (2019-2030)
3.7.3 Latin America Nicotinamide Mononucleotide Supplement Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Nicotinamide Mononucleotide Supplement Market Facts & Figures by Country
3.8.1 Middle East and Africa Nicotinamide Mononucleotide Supplement Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Nicotinamide Mononucleotide Supplement Sales by Country (2019-2030)
3.8.3 Middle East and Africa Nicotinamide Mononucleotide Supplement Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Nicotinamide Mononucleotide Supplement Sales by Type (2019-2030)
4.1.1 Global Nicotinamide Mononucleotide Supplement Sales by Type (2019-2024)
4.1.2 Global Nicotinamide Mononucleotide Supplement Sales by Type (2025-2030)
4.1.3 Global Nicotinamide Mononucleotide Supplement Sales Market Share by Type (2019-2030)
4.2 Global Nicotinamide Mononucleotide Supplement Revenue by Type (2019-2030)
4.2.1 Global Nicotinamide Mononucleotide Supplement Revenue by Type (2019-2024)
4.2.2 Global Nicotinamide Mononucleotide Supplement Revenue by Type (2025-2030)
4.2.3 Global Nicotinamide Mononucleotide Supplement Revenue Market Share by Type (2019-2030)
4.3 Global Nicotinamide Mononucleotide Supplement Price by Type (2019-2030)
5 Segment by Application
5.1 Global Nicotinamide Mononucleotide Supplement Sales by Application (2019-2030)
5.1.1 Global Nicotinamide Mononucleotide Supplement Sales by Application (2019-2024)
5.1.2 Global Nicotinamide Mononucleotide Supplement Sales by Application (2025-2030)
5.1.3 Global Nicotinamide Mononucleotide Supplement Sales Market Share by Application (2019-2030)
5.2 Global Nicotinamide Mononucleotide Supplement Revenue by Application (2019-2030)
5.2.1 Global Nicotinamide Mononucleotide Supplement Revenue by Application (2019-2024)
5.2.2 Global Nicotinamide Mononucleotide Supplement Revenue by Application (2025-2030)
5.2.3 Global Nicotinamide Mononucleotide Supplement Revenue Market Share by Application (2019-2030)
5.3 Global Nicotinamide Mononucleotide Supplement Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Double Wood Supplements
6.1.1 Double Wood Supplements Corporation Information
6.1.2 Double Wood Supplements Description and Business Overview
6.1.3 Double Wood Supplements Nicotinamide Mononucleotide Supplement Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Double Wood Supplements Nicotinamide Mononucleotide Supplement Product Portfolio
6.1.5 Double Wood Supplements Recent Developments/Updates
6.2 Quicksilver Scientific
6.2.1 Quicksilver Scientific Corporation Information
6.2.2 Quicksilver Scientific Description and Business Overview
6.2.3 Quicksilver Scientific Nicotinamide Mononucleotide Supplement Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Quicksilver Scientific Nicotinamide Mononucleotide Supplement Product Portfolio
6.2.5 Quicksilver Scientific Recent Developments/Updates
6.3 California Gold Nutrition
6.3.1 California Gold Nutrition Corporation Information
6.3.2 California Gold Nutrition Description and Business Overview
6.3.3 California Gold Nutrition Nicotinamide Mononucleotide Supplement Sales, Revenue and Gross Margin (2019-2024)
6.3.4 California Gold Nutrition Nicotinamide Mononucleotide Supplement Product Portfolio
6.3.5 California Gold Nutrition Recent Developments/Updates
6.4 ProHealth Longevity
6.4.1 ProHealth Longevity Corporation Information
6.4.2 ProHealth Longevity Description and Business Overview
6.4.3 ProHealth Longevity Nicotinamide Mononucleotide Supplement Sales, Revenue and Gross Margin (2019-2024)
6.4.4 ProHealth Longevity Nicotinamide Mononucleotide Supplement Product Portfolio
6.4.5 ProHealth Longevity Recent Developments/Updates
6.5 Renue by Science
6.5.1 Renue by Science Corporation Information
6.5.2 Renue by Science Description and Business Overview
6.5.3 Renue by Science Nicotinamide Mononucleotide Supplement Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Renue by Science Nicotinamide Mononucleotide Supplement Product Portfolio
6.5.5 Renue by Science Recent Developments/Updates
6.6 Do Not Age
6.6.1 Do Not Age Corporation Information
6.6.2 Do Not Age Description and Business Overview
6.6.3 Do Not Age Nicotinamide Mononucleotide Supplement Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Do Not Age Nicotinamide Mononucleotide Supplement Product Portfolio
6.6.5 Do Not Age Recent Developments/Updates
6.7 Nutriop
6.6.1 Nutriop Corporation Information
6.6.2 Nutriop Description and Business Overview
6.6.3 Nutriop Nicotinamide Mononucleotide Supplement Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Nutriop Nicotinamide Mononucleotide Supplement Product Portfolio
6.7.5 Nutriop Recent Developments/Updates
6.8 AFEGA Anti-Aging-Shop
6.8.1 AFEGA Anti-Aging-Shop Corporation Information
6.8.2 AFEGA Anti-Aging-Shop Description and Business Overview
6.8.3 AFEGA Anti-Aging-Shop Nicotinamide Mononucleotide Supplement Sales, Revenue and Gross Margin (2019-2024)
6.8.4 AFEGA Anti-Aging-Shop Nicotinamide Mononucleotide Supplement Product Portfolio
6.8.5 AFEGA Anti-Aging-Shop Recent Developments/Updates
6.9 Borealis
6.9.1 Borealis Corporation Information
6.9.2 Borealis Description and Business Overview
6.9.3 Borealis Nicotinamide Mononucleotide Supplement Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Borealis Nicotinamide Mononucleotide Supplement Product Portfolio
6.9.5 Borealis Recent Developments/Updates
6.10 MAAC10 Formulas
6.10.1 MAAC10 Formulas Corporation Information
6.10.2 MAAC10 Formulas Description and Business Overview
6.10.3 MAAC10 Formulas Nicotinamide Mononucleotide Supplement Sales, Revenue and Gross Margin (2019-2024)
6.10.4 MAAC10 Formulas Nicotinamide Mononucleotide Supplement Product Portfolio
6.10.5 MAAC10 Formulas Recent Developments/Updates
6.11 Xi'an Angel Biotechnology Co., Ltd.
6.11.1 Xi'an Angel Biotechnology Co., Ltd. Corporation Information
6.11.2 Xi'an Angel Biotechnology Co., Ltd. Nicotinamide Mononucleotide Supplement Description and Business Overview
6.11.3 Xi'an Angel Biotechnology Co., Ltd. Nicotinamide Mononucleotide Supplement Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Xi'an Angel Biotechnology Co., Ltd. Nicotinamide Mononucleotide Supplement Product Portfolio
6.11.5 Xi'an Angel Biotechnology Co., Ltd. Recent Developments/Updates
6.12 Longevity Box
6.12.1 Longevity Box Corporation Information
6.12.2 Longevity Box Nicotinamide Mononucleotide Supplement Description and Business Overview
6.12.3 Longevity Box Nicotinamide Mononucleotide Supplement Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Longevity Box Nicotinamide Mononucleotide Supplement Product Portfolio
6.12.5 Longevity Box Recent Developments/Updates
6.13 Age Science
6.13.1 Age Science Corporation Information
6.13.2 Age Science Nicotinamide Mononucleotide Supplement Description and Business Overview
6.13.3 Age Science Nicotinamide Mononucleotide Supplement Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Age Science Nicotinamide Mononucleotide Supplement Product Portfolio
6.13.5 Age Science Recent Developments/Updates
6.14 Nutravita
6.14.1 Nutravita Corporation Information
6.14.2 Nutravita Nicotinamide Mononucleotide Supplement Description and Business Overview
6.14.3 Nutravita Nicotinamide Mononucleotide Supplement Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Nutravita Nicotinamide Mononucleotide Supplement Product Portfolio
6.14.5 Nutravita Recent Developments/Updates
6.15 Hebei Paihang Import And Export Co., Ltd.
6.15.1 Hebei Paihang Import And Export Co., Ltd. Corporation Information
6.15.2 Hebei Paihang Import And Export Co., Ltd. Nicotinamide Mononucleotide Supplement Description and Business Overview
6.15.3 Hebei Paihang Import And Export Co., Ltd. Nicotinamide Mononucleotide Supplement Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Hebei Paihang Import And Export Co., Ltd. Nicotinamide Mononucleotide Supplement Product Portfolio
6.15.5 Hebei Paihang Import And Export Co., Ltd. Recent Developments/Updates
6.16 Aeternum
6.16.1 Aeternum Corporation Information
6.16.2 Aeternum Nicotinamide Mononucleotide Supplement Description and Business Overview
6.16.3 Aeternum Nicotinamide Mononucleotide Supplement Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Aeternum Nicotinamide Mononucleotide Supplement Product Portfolio
6.16.5 Aeternum Recent Developments/Updates
6.17 Toniiq
6.17.1 Toniiq Corporation Information
6.17.2 Toniiq Nicotinamide Mononucleotide Supplement Description and Business Overview
6.17.3 Toniiq Nicotinamide Mononucleotide Supplement Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Toniiq Nicotinamide Mononucleotide Supplement Product Portfolio
6.17.5 Toniiq Recent Developments/Updates
6.18 ProNutrition
6.18.1 ProNutrition Corporation Information
6.18.2 ProNutrition Nicotinamide Mononucleotide Supplement Description and Business Overview
6.18.3 ProNutrition Nicotinamide Mononucleotide Supplement Sales, Revenue and Gross Margin (2019-2024)
6.18.4 ProNutrition Nicotinamide Mononucleotide Supplement Product Portfolio
6.18.5 ProNutrition Recent Developments/Updates
6.19 Genex Formulas
6.19.1 Genex Formulas Corporation Information
6.19.2 Genex Formulas Nicotinamide Mononucleotide Supplement Description and Business Overview
6.19.3 Genex Formulas Nicotinamide Mononucleotide Supplement Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Genex Formulas Nicotinamide Mononucleotide Supplement Product Portfolio
6.19.5 Genex Formulas Recent Developments/Updates
6.20 Physicians Longevity
6.20.1 Physicians Longevity Corporation Information
6.20.2 Physicians Longevity Nicotinamide Mononucleotide Supplement Description and Business Overview
6.20.3 Physicians Longevity Nicotinamide Mononucleotide Supplement Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Physicians Longevity Nicotinamide Mononucleotide Supplement Product Portfolio
6.20.5 Physicians Longevity Recent Developments/Updates
6.21 AlphaFit
6.21.1 AlphaFit Corporation Information
6.21.2 AlphaFit Nicotinamide Mononucleotide Supplement Description and Business Overview
6.21.3 AlphaFit Nicotinamide Mononucleotide Supplement Sales, Revenue and Gross Margin (2019-2024)
6.21.4 AlphaFit Nicotinamide Mononucleotide Supplement Product Portfolio
6.21.5 AlphaFit Recent Developments/Updates
6.22 Mega NMN
6.22.1 Mega NMN Corporation Information
6.22.2 Mega NMN Nicotinamide Mononucleotide Supplement Description and Business Overview
6.22.3 Mega NMN Nicotinamide Mononucleotide Supplement Sales, Revenue and Gross Margin (2019-2024)
6.22.4 Mega NMN Nicotinamide Mononucleotide Supplement Product Portfolio
6.22.5 Mega NMN Recent Developments/Updates
6.23 Lovita Foods
6.23.1 Lovita Foods Corporation Information
6.23.2 Lovita Foods Nicotinamide Mononucleotide Supplement Description and Business Overview
6.23.3 Lovita Foods Nicotinamide Mononucleotide Supplement Sales, Revenue and Gross Margin (2019-2024)
6.23.4 Lovita Foods Nicotinamide Mononucleotide Supplement Product Portfolio
6.23.5 Lovita Foods Recent Developments/Updates
6.24 Jarrow Formulas
6.24.1 Jarrow Formulas Corporation Information
6.24.2 Jarrow Formulas Nicotinamide Mononucleotide Supplement Description and Business Overview
6.24.3 Jarrow Formulas Nicotinamide Mononucleotide Supplement Sales, Revenue and Gross Margin (2019-2024)
6.24.4 Jarrow Formulas Nicotinamide Mononucleotide Supplement Product Portfolio
6.24.5 Jarrow Formulas Recent Developments/Updates
6.25 Body Union
6.25.1 Body Union Corporation Information
6.25.2 Body Union Nicotinamide Mononucleotide Supplement Description and Business Overview
6.25.3 Body Union Nicotinamide Mononucleotide Supplement Sales, Revenue and Gross Margin (2019-2024)
6.25.4 Body Union Nicotinamide Mononucleotide Supplement Product Portfolio
6.25.5 Body Union Recent Developments/Updates
6.26 Peak Performance
6.26.1 Peak Performance Corporation Information
6.26.2 Peak Performance Nicotinamide Mononucleotide Supplement Description and Business Overview
6.26.3 Peak Performance Nicotinamide Mononucleotide Supplement Sales, Revenue and Gross Margin (2019-2024)
6.26.4 Peak Performance Nicotinamide Mononucleotide Supplement Product Portfolio
6.26.5 Peak Performance Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nicotinamide Mononucleotide Supplement Industry Chain Analysis
7.2 Nicotinamide Mononucleotide Supplement Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nicotinamide Mononucleotide Supplement Production Mode & Process
7.4 Nicotinamide Mononucleotide Supplement Sales and Marketing
7.4.1 Nicotinamide Mononucleotide Supplement Sales Channels
7.4.2 Nicotinamide Mononucleotide Supplement Distributors
7.5 Nicotinamide Mononucleotide Supplement Customers
8 Nicotinamide Mononucleotide Supplement Market Dynamics
8.1 Nicotinamide Mononucleotide Supplement Industry Trends
8.2 Nicotinamide Mononucleotide Supplement Market Drivers
8.3 Nicotinamide Mononucleotide Supplement Market Challenges
8.4 Nicotinamide Mononucleotide Supplement Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Nicotinamide Mononucleotide Supplement Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Nicotinamide Mononucleotide Supplement Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Nicotinamide Mononucleotide Supplement Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Nicotinamide Mononucleotide Supplement Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Nicotinamide Mononucleotide Supplement Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Nicotinamide Mononucleotide Supplement Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Nicotinamide Mononucleotide Supplement Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Nicotinamide Mononucleotide Supplement Average Price (US$/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Nicotinamide Mononucleotide Supplement, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Nicotinamide Mononucleotide Supplement, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Nicotinamide Mononucleotide Supplement, Product Type & Application
    Table 12. Global Key Manufacturers of Nicotinamide Mononucleotide Supplement, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Nicotinamide Mononucleotide Supplement by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nicotinamide Mononucleotide Supplement as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Nicotinamide Mononucleotide Supplement Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Nicotinamide Mononucleotide Supplement Sales by Region (2019-2024) & (K Units)
    Table 18. Global Nicotinamide Mononucleotide Supplement Sales Market Share by Region (2019-2024)
    Table 19. Global Nicotinamide Mononucleotide Supplement Sales by Region (2025-2030) & (K Units)
    Table 20. Global Nicotinamide Mononucleotide Supplement Sales Market Share by Region (2025-2030)
    Table 21. Global Nicotinamide Mononucleotide Supplement Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Nicotinamide Mononucleotide Supplement Revenue Market Share by Region (2019-2024)
    Table 23. Global Nicotinamide Mononucleotide Supplement Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Nicotinamide Mononucleotide Supplement Revenue Market Share by Region (2025-2030)
    Table 25. North America Nicotinamide Mononucleotide Supplement Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Nicotinamide Mononucleotide Supplement Sales by Country (2019-2024) & (K Units)
    Table 27. North America Nicotinamide Mononucleotide Supplement Sales by Country (2025-2030) & (K Units)
    Table 28. North America Nicotinamide Mononucleotide Supplement Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Nicotinamide Mononucleotide Supplement Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Nicotinamide Mononucleotide Supplement Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Nicotinamide Mononucleotide Supplement Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Nicotinamide Mononucleotide Supplement Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Nicotinamide Mononucleotide Supplement Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Nicotinamide Mononucleotide Supplement Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Nicotinamide Mononucleotide Supplement Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Nicotinamide Mononucleotide Supplement Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Nicotinamide Mononucleotide Supplement Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Nicotinamide Mononucleotide Supplement Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Nicotinamide Mononucleotide Supplement Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Nicotinamide Mononucleotide Supplement Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Nicotinamide Mononucleotide Supplement Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Nicotinamide Mononucleotide Supplement Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Nicotinamide Mononucleotide Supplement Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Nicotinamide Mononucleotide Supplement Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Nicotinamide Mononucleotide Supplement Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Nicotinamide Mononucleotide Supplement Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Nicotinamide Mononucleotide Supplement Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Nicotinamide Mononucleotide Supplement Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Nicotinamide Mononucleotide Supplement Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Nicotinamide Mononucleotide Supplement Sales (K Units) by Type (2019-2024)
    Table 51. Global Nicotinamide Mononucleotide Supplement Sales (K Units) by Type (2025-2030)
    Table 52. Global Nicotinamide Mononucleotide Supplement Sales Market Share by Type (2019-2024)
    Table 53. Global Nicotinamide Mononucleotide Supplement Sales Market Share by Type (2025-2030)
    Table 54. Global Nicotinamide Mononucleotide Supplement Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Nicotinamide Mononucleotide Supplement Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Nicotinamide Mononucleotide Supplement Revenue Market Share by Type (2019-2024)
    Table 57. Global Nicotinamide Mononucleotide Supplement Revenue Market Share by Type (2025-2030)
    Table 58. Global Nicotinamide Mononucleotide Supplement Price (US$/Unit) by Type (2019-2024)
    Table 59. Global Nicotinamide Mononucleotide Supplement Price (US$/Unit) by Type (2025-2030)
    Table 60. Global Nicotinamide Mononucleotide Supplement Sales (K Units) by Application (2019-2024)
    Table 61. Global Nicotinamide Mononucleotide Supplement Sales (K Units) by Application (2025-2030)
    Table 62. Global Nicotinamide Mononucleotide Supplement Sales Market Share by Application (2019-2024)
    Table 63. Global Nicotinamide Mononucleotide Supplement Sales Market Share by Application (2025-2030)
    Table 64. Global Nicotinamide Mononucleotide Supplement Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Nicotinamide Mononucleotide Supplement Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Nicotinamide Mononucleotide Supplement Revenue Market Share by Application (2019-2024)
    Table 67. Global Nicotinamide Mononucleotide Supplement Revenue Market Share by Application (2025-2030)
    Table 68. Global Nicotinamide Mononucleotide Supplement Price (US$/Unit) by Application (2019-2024)
    Table 69. Global Nicotinamide Mononucleotide Supplement Price (US$/Unit) by Application (2025-2030)
    Table 70. Double Wood Supplements Corporation Information
    Table 71. Double Wood Supplements Description and Business Overview
    Table 72. Double Wood Supplements Nicotinamide Mononucleotide Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 73. Double Wood Supplements Nicotinamide Mononucleotide Supplement Product
    Table 74. Double Wood Supplements Recent Developments/Updates
    Table 75. Quicksilver Scientific Corporation Information
    Table 76. Quicksilver Scientific Description and Business Overview
    Table 77. Quicksilver Scientific Nicotinamide Mononucleotide Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 78. Quicksilver Scientific Nicotinamide Mononucleotide Supplement Product
    Table 79. Quicksilver Scientific Recent Developments/Updates
    Table 80. California Gold Nutrition Corporation Information
    Table 81. California Gold Nutrition Description and Business Overview
    Table 82. California Gold Nutrition Nicotinamide Mononucleotide Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 83. California Gold Nutrition Nicotinamide Mononucleotide Supplement Product
    Table 84. California Gold Nutrition Recent Developments/Updates
    Table 85. ProHealth Longevity Corporation Information
    Table 86. ProHealth Longevity Description and Business Overview
    Table 87. ProHealth Longevity Nicotinamide Mononucleotide Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 88. ProHealth Longevity Nicotinamide Mononucleotide Supplement Product
    Table 89. ProHealth Longevity Recent Developments/Updates
    Table 90. Renue by Science Corporation Information
    Table 91. Renue by Science Description and Business Overview
    Table 92. Renue by Science Nicotinamide Mononucleotide Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 93. Renue by Science Nicotinamide Mononucleotide Supplement Product
    Table 94. Renue by Science Recent Developments/Updates
    Table 95. Do Not Age Corporation Information
    Table 96. Do Not Age Description and Business Overview
    Table 97. Do Not Age Nicotinamide Mononucleotide Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 98. Do Not Age Nicotinamide Mononucleotide Supplement Product
    Table 99. Do Not Age Recent Developments/Updates
    Table 100. Nutriop Corporation Information
    Table 101. Nutriop Description and Business Overview
    Table 102. Nutriop Nicotinamide Mononucleotide Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 103. Nutriop Nicotinamide Mononucleotide Supplement Product
    Table 104. Nutriop Recent Developments/Updates
    Table 105. AFEGA Anti-Aging-Shop Corporation Information
    Table 106. AFEGA Anti-Aging-Shop Description and Business Overview
    Table 107. AFEGA Anti-Aging-Shop Nicotinamide Mononucleotide Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 108. AFEGA Anti-Aging-Shop Nicotinamide Mononucleotide Supplement Product
    Table 109. AFEGA Anti-Aging-Shop Recent Developments/Updates
    Table 110. Borealis Corporation Information
    Table 111. Borealis Description and Business Overview
    Table 112. Borealis Nicotinamide Mononucleotide Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 113. Borealis Nicotinamide Mononucleotide Supplement Product
    Table 114. Borealis Recent Developments/Updates
    Table 115. MAAC10 Formulas Corporation Information
    Table 116. MAAC10 Formulas Description and Business Overview
    Table 117. MAAC10 Formulas Nicotinamide Mononucleotide Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 118. MAAC10 Formulas Nicotinamide Mononucleotide Supplement Product
    Table 119. MAAC10 Formulas Recent Developments/Updates
    Table 120. Xi'an Angel Biotechnology Co., Ltd. Corporation Information
    Table 121. Xi'an Angel Biotechnology Co., Ltd. Description and Business Overview
    Table 122. Xi'an Angel Biotechnology Co., Ltd. Nicotinamide Mononucleotide Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 123. Xi'an Angel Biotechnology Co., Ltd. Nicotinamide Mononucleotide Supplement Product
    Table 124. Xi'an Angel Biotechnology Co., Ltd. Recent Developments/Updates
    Table 125. Longevity Box Corporation Information
    Table 126. Longevity Box Description and Business Overview
    Table 127. Longevity Box Nicotinamide Mononucleotide Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 128. Longevity Box Nicotinamide Mononucleotide Supplement Product
    Table 129. Longevity Box Recent Developments/Updates
    Table 130. Age Science Corporation Information
    Table 131. Age Science Description and Business Overview
    Table 132. Age Science Nicotinamide Mononucleotide Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 133. Age Science Nicotinamide Mononucleotide Supplement Product
    Table 134. Age Science Recent Developments/Updates
    Table 135. Nutravita Corporation Information
    Table 136. Nutravita Description and Business Overview
    Table 137. Nutravita Nicotinamide Mononucleotide Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 138. Nutravita Nicotinamide Mononucleotide Supplement Product
    Table 139. Nutravita Recent Developments/Updates
    Table 140. Hebei Paihang Import And Export Co., Ltd. Corporation Information
    Table 141. Hebei Paihang Import And Export Co., Ltd. Description and Business Overview
    Table 142. Hebei Paihang Import And Export Co., Ltd. Nicotinamide Mononucleotide Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 143. Hebei Paihang Import And Export Co., Ltd. Nicotinamide Mononucleotide Supplement Product
    Table 144. Hebei Paihang Import And Export Co., Ltd. Recent Developments/Updates
    Table 145. Aeternum Corporation Information
    Table 146. Aeternum Description and Business Overview
    Table 147. Aeternum Nicotinamide Mononucleotide Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 148. Aeternum Nicotinamide Mononucleotide Supplement Product
    Table 149. Aeternum Recent Developments/Updates
    Table 150. Toniiq Corporation Information
    Table 151. Toniiq Description and Business Overview
    Table 152. Toniiq Nicotinamide Mononucleotide Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 153. Toniiq Nicotinamide Mononucleotide Supplement Product
    Table 154. Toniiq Recent Developments/Updates
    Table 155. ProNutrition Corporation Information
    Table 156. ProNutrition Description and Business Overview
    Table 157. ProNutrition Nicotinamide Mononucleotide Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 158. ProNutrition Nicotinamide Mononucleotide Supplement Product
    Table 159. ProNutrition Recent Developments/Updates
    Table 160. Genex Formulas Corporation Information
    Table 161. Genex Formulas Description and Business Overview
    Table 162. Genex Formulas Nicotinamide Mononucleotide Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 163. Genex Formulas Nicotinamide Mononucleotide Supplement Product
    Table 164. Genex Formulas Recent Developments/Updates
    Table 165. Physicians Longevity Corporation Information
    Table 166. Physicians Longevity Description and Business Overview
    Table 167. Physicians Longevity Nicotinamide Mononucleotide Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 168. Physicians Longevity Nicotinamide Mononucleotide Supplement Product
    Table 169. Physicians Longevity Recent Developments/Updates
    Table 170. AlphaFit Corporation Information
    Table 171. AlphaFit Description and Business Overview
    Table 172. AlphaFit Nicotinamide Mononucleotide Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 173. AlphaFit Nicotinamide Mononucleotide Supplement Product
    Table 174. AlphaFit Recent Developments/Updates
    Table 175. Mega NMN Corporation Information
    Table 176. Mega NMN Description and Business Overview
    Table 177. Mega NMN Nicotinamide Mononucleotide Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 178. Mega NMN Nicotinamide Mononucleotide Supplement Product
    Table 179. Mega NMN Recent Developments/Updates
    Table 180. Lovita Foods Corporation Information
    Table 181. Lovita Foods Description and Business Overview
    Table 182. Lovita Foods Nicotinamide Mononucleotide Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 183. Lovita Foods Nicotinamide Mononucleotide Supplement Product
    Table 184. Lovita Foods Recent Developments/Updates
    Table 185. Jarrow Formulas Corporation Information
    Table 186. Jarrow Formulas Description and Business Overview
    Table 187. Jarrow Formulas Nicotinamide Mononucleotide Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 188. Jarrow Formulas Nicotinamide Mononucleotide Supplement Product
    Table 189. Jarrow Formulas Recent Developments/Updates
    Table 190. Body Union Corporation Information
    Table 191. Body Union Description and Business Overview
    Table 192. Body Union Nicotinamide Mononucleotide Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 193. Body Union Nicotinamide Mononucleotide Supplement Product
    Table 194. Body Union Recent Developments/Updates
    Table 195. Peak Performance Corporation Information
    Table 196. Peak Performance Description and Business Overview
    Table 197. Peak Performance Nicotinamide Mononucleotide Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 198. Peak Performance Nicotinamide Mononucleotide Supplement Product
    Table 199. Peak Performance Recent Developments/Updates
    Table 200. Key Raw Materials Lists
    Table 201. Raw Materials Key Suppliers Lists
    Table 202. Nicotinamide Mononucleotide Supplement Distributors List
    Table 203. Nicotinamide Mononucleotide Supplement Customers List
    Table 204. Nicotinamide Mononucleotide Supplement Market Trends
    Table 205. Nicotinamide Mononucleotide Supplement Market Drivers
    Table 206. Nicotinamide Mononucleotide Supplement Market Challenges
    Table 207. Nicotinamide Mononucleotide Supplement Market Restraints
    Table 208. Research Programs/Design for This Report
    Table 209. Key Data Information from Secondary Sources
    Table 210. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Nicotinamide Mononucleotide Supplement
    Figure 2. Global Nicotinamide Mononucleotide Supplement Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Nicotinamide Mononucleotide Supplement Market Share by Type in 2023 & 2030
    Figure 4. Powder Product Picture
    Figure 5. Tablets Product Picture
    Figure 6. Solution Product Picture
    Figure 7. Capsules Product Picture
    Figure 8. Global Nicotinamide Mononucleotide Supplement Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 9. Global Nicotinamide Mononucleotide Supplement Market Share by Application in 2023 & 2030
    Figure 10. Online Sales
    Figure 11. Pharmacy Sales
    Figure 12. Supermarket Sales
    Figure 13. Global Nicotinamide Mononucleotide Supplement Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Nicotinamide Mononucleotide Supplement Market Size (2019-2030) & (US$ Million)
    Figure 15. Global Nicotinamide Mononucleotide Supplement Sales (2019-2030) & (K Units)
    Figure 16. Global Nicotinamide Mononucleotide Supplement Average Price (US$/Unit) & (2019-2030)
    Figure 17. Nicotinamide Mononucleotide Supplement Report Years Considered
    Figure 18. Nicotinamide Mononucleotide Supplement Sales Share by Manufacturers in 2023
    Figure 19. Global Nicotinamide Mononucleotide Supplement Revenue Share by Manufacturers in 2023
    Figure 20. The Global 5 and 10 Largest Nicotinamide Mononucleotide Supplement Players: Market Share by Revenue in 2023
    Figure 21. Nicotinamide Mononucleotide Supplement Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 22. Global Nicotinamide Mononucleotide Supplement Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 23. North America Nicotinamide Mononucleotide Supplement Sales Market Share by Country (2019-2030)
    Figure 24. North America Nicotinamide Mononucleotide Supplement Revenue Market Share by Country (2019-2030)
    Figure 25. United States Nicotinamide Mononucleotide Supplement Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 26. Canada Nicotinamide Mononucleotide Supplement Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 27. Europe Nicotinamide Mononucleotide Supplement Sales Market Share by Country (2019-2030)
    Figure 28. Europe Nicotinamide Mononucleotide Supplement Revenue Market Share by Country (2019-2030)
    Figure 29. Germany Nicotinamide Mononucleotide Supplement Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. France Nicotinamide Mononucleotide Supplement Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. U.K. Nicotinamide Mononucleotide Supplement Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Italy Nicotinamide Mononucleotide Supplement Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. Russia Nicotinamide Mononucleotide Supplement Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. Asia Pacific Nicotinamide Mononucleotide Supplement Sales Market Share by Region (2019-2030)
    Figure 35. Asia Pacific Nicotinamide Mononucleotide Supplement Revenue Market Share by Region (2019-2030)
    Figure 36. China Nicotinamide Mononucleotide Supplement Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. Japan Nicotinamide Mononucleotide Supplement Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. South Korea Nicotinamide Mononucleotide Supplement Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. India Nicotinamide Mononucleotide Supplement Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Australia Nicotinamide Mononucleotide Supplement Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. China Taiwan Nicotinamide Mononucleotide Supplement Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Indonesia Nicotinamide Mononucleotide Supplement Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Thailand Nicotinamide Mononucleotide Supplement Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Malaysia Nicotinamide Mononucleotide Supplement Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Latin America Nicotinamide Mononucleotide Supplement Sales Market Share by Country (2019-2030)
    Figure 46. Latin America Nicotinamide Mononucleotide Supplement Revenue Market Share by Country (2019-2030)
    Figure 47. Mexico Nicotinamide Mononucleotide Supplement Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Brazil Nicotinamide Mononucleotide Supplement Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Argentina Nicotinamide Mononucleotide Supplement Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. Middle East & Africa Nicotinamide Mononucleotide Supplement Sales Market Share by Country (2019-2030)
    Figure 51. Middle East & Africa Nicotinamide Mononucleotide Supplement Revenue Market Share by Country (2019-2030)
    Figure 52. Turkey Nicotinamide Mononucleotide Supplement Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. Saudi Arabia Nicotinamide Mononucleotide Supplement Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. UAE Nicotinamide Mononucleotide Supplement Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 55. Global Sales Market Share of Nicotinamide Mononucleotide Supplement by Type (2019-2030)
    Figure 56. Global Revenue Market Share of Nicotinamide Mononucleotide Supplement by Type (2019-2030)
    Figure 57. Global Nicotinamide Mononucleotide Supplement Price (US$/Unit) by Type (2019-2030)
    Figure 58. Global Sales Market Share of Nicotinamide Mononucleotide Supplement by Application (2019-2030)
    Figure 59. Global Revenue Market Share of Nicotinamide Mononucleotide Supplement by Application (2019-2030)
    Figure 60. Global Nicotinamide Mononucleotide Supplement Price (US$/Unit) by Application (2019-2030)
    Figure 61. Nicotinamide Mononucleotide Supplement Value Chain
    Figure 62. Nicotinamide Mononucleotide Supplement Production Process
    Figure 63. Channels of Distribution (Direct Vs Distribution)
    Figure 64. Distributors Profiles
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global High Purity Nisin Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-39A7896
Sun May 19 00:00:00 UTC 2024

Add to Cart

Global Calcium Tablet and Oral Liquid Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-37K7959
Sun May 19 00:00:00 UTC 2024

Add to Cart

Global Kidney Machines Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-6E8305
Sun May 19 00:00:00 UTC 2024

Add to Cart

Global Soft Capsules Drugs Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-19B5833
Sun May 19 00:00:00 UTC 2024

Add to Cart